Result of AGM

RNS Number : 1567L

Hutchison China Meditech Limited

30 April 2010

 



Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

Results of Annual General Meeting

London: Friday, 30 April 2010:Chi-Med today announces that all ordinary resolutions and special resolution put to its Annual General Meeting ("AGM") held on 30 April 2010 were duly passed.  The poll results of the resolutions were as follows:

		Number of Votes (%)*
Ordinary Resolutions		For	Against	Withheld
1	To consider and adopt the statement of audited accounts and the reports of the directors and independent auditor for the year ended 31 December 2009.	41,414,053 (96.431009%)	30 (0.000070%)	1,532,738 (3.568921%)
2(a)	To re-elect Mr Christian Hogg as a director.	42,946,821 (100%)	0 (0%)	0 (0%)
2(b)	To re-elect Mr Michael Howell as a director.	42,921,821 (99.941788%)	0 (0%)	25,000 (0.058212%)
2(c)	To re-elect Mr Christian Salbaing as a director.	42,946,791 (99.999930%)	30 (0.000070%)	0 (0%)
3	To re-appoint PricewaterhouseCoopers as the auditor of the Company and authorise the board of directors to fix the auditor's remuneration.	42,946,571 (99.999418%)	0 (0%)	250 (0.000582%)
4(a)	Item 4(A) of the notice of the Meeting (To grant a general mandate to the directors of the Company to issue additional shares)	42,946,791 (99.999930%)	30 (0.000070%)	0 (0%)
Special Resolution
4(b)	Item 4(B) of the notice of the Meeting (To disapply pre-emption rights)	42,946,691 (99.999697%)	130 (0.000303%)	0 (0%)
Ordinary Resolution
4(c)	Item 4(C) of the notice of the Meeting (To grant a general mandate to the directors of the Company to repurchase shares of the Company)	42,946,821 (100%)	0 (0%)	0 (0%)

* Percentages rounded to 6 decimal places

As at the date of the AGM, the number of issued shares of Chi-Med was 51,314,440, which was the total number of shares entitling the holders to attend and vote on the ordinary resolutions and special resolution proposed at the AGM. 

Ends

Enquiries

Citigate Dewe Rogerson Anthony Carlisle David Dible	Telephone: [phone] [phone] [phone]
Lazard & Co., Limited Paul Gismondi Nick Fowler	Telephone: [phone]

About Chi-Med

Chi-Med is the holding company of a pharmaceutical and healthcare group based primarily in China and was admitted to trading on the Alternative Investment Market of the London Stock Exchange in May 2006.  It is focused on researching, developing, manufacturing, and selling pharmaceuticals and health oriented consumer products.

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.

 

END

 

 

RAGSDMFESFSSEFL